Interaction of Carrier Protein with Potential Metallic Drug Candidate N-Glycoside ‘GATPT’: Validation by Multi-Spectroscopic and Molecular Docking Approaches
Abstract
:1. Introduction
2. Results and Discussions
2.1. Conformational Changes in Lysozyme Investigated by UV–Visible Spectroscopy
2.2. Intrinsic Fluorescence Measurements
2.3. Thermodynamic Parameters and Binding Modes
2.4. Conformational Transitions Monitored by CD
2.5. Binding Location of GATPT within the Lysozyme: Molecular Docking Studies
2.6. Confocal Laser Scanning Microscopy of the Complex and Lysozyme and Lysozyme-DNA Condensate
2.7. Scanning Electron Microscopy (SEM)
3. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Sample Availability
References
- Sleep, D.; Cameron, J.; Evans, L.R. Albumin as a versatile platform for drug half-life extension. Biochim. Biophys. Acta 2013, 1830, 5526–5534. [Google Scholar] [CrossRef]
- Nassab, C.N.; Arooj, M.; Shehadi, I.A.; Parambath, J.B.M.; Kanan, S.M.; Mohamed, A.A. Lysozyme and Human Serum Albumin Proteins as Potential Nitric Oxide Cardiovascular Drug Carriers: Theoretical and Experimental Investigation. J. Phys. Chem. B 2021, 125, 7750–7762. [Google Scholar] [CrossRef]
- Bolel, P.; Datta, S.; Mahapatra, N.; Halder, M. Spectroscopic Investigation of the Effect of Salt on Binding of Tartrazine with Two Homologous Serum Albumins: Quantification by Use of the Debye–Hückel Limiting Law and Observation of Enthalpy–Entropy Compensation. J. Phys. Chem. B 2012, 116, 10195–10204. [Google Scholar] [CrossRef] [PubMed]
- Alam, P.; Abdelhameed, A.S.; Rajpoot, R.K.; Khan, R.H. Interplay of multiple interaction forces: Binding of tyrosine kinase inhibitor nintedanib with human serum albumin. J. Photochem. Photobiol. B Biol. 2016, 157, 70–76. [Google Scholar] [CrossRef] [PubMed]
- Yue, Y.; Wang, Z.; Wang, Z.; Zhang, Y.; Liu, J. A comparative study of binding properties of different coumarin-based compounds with human serum albumin. J. Mol. Struct. 2018, 1169, 75–80. [Google Scholar] [CrossRef]
- Wang, X.; Yue, Y.; Zhang, Y.; Wang, Z.; Liu, J.; Tang, Q. Probing the interaction of pepsin with imidacloprid via DFT calculation, spectroscopic approaches and molecular docking. J. Mol. Struct. 2019, 1197, 210–216. [Google Scholar] [CrossRef]
- Liu, J.; Yan, X.; Yue, Y.; Zhao, S. Investigation of the interaction of aurantio-obtusin with human serum albumin by spectroscopic and molecular docking methods. Luminescence 2018, 33, 104–111. [Google Scholar] [CrossRef]
- Singh, S.S.; Mehta, J. Measurement of drug–protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration. J. Chromatogr. B 2006, 834, 108–116. [Google Scholar] [CrossRef]
- Ali, M.S.; Al-Lohedan, H.A. Spectroscopic and Molecular Docking Investigation on the Noncovalent Interaction of Lysozyme with Saffron Constituent “Safranal”. ACS Omega 2020, 5, 9131–9141. [Google Scholar] [CrossRef] [PubMed]
- Das, S.; Hazarika, Z.; Sarmah, S.; Baruah, K.; Rohman, M.A.; Paul, D.; Jha, A.N.; Roy, A.S. Exploring the interaction of bioactive kaempferol with serum albumin, lysozyme and hemoglobin: A biophysical investigation using multi-spectroscopic, docking and molecular dynamics simulation studies. J. Photochem. Photobiol. B Biol. 2020, 205, 111825. [Google Scholar] [CrossRef]
- Blake, C.C.F.; Koenig, D.F.; Mair, G.A.; North, A.C.T.; Phillips, D.C.; Sarma, V.R. Structure of hen egg-white lysozyme: A three-dimensional Fourier synthesis at 2 Å resolution. Nature 1965, 206, 757–761. [Google Scholar] [CrossRef]
- Saha, S.; Chowdhury, J. Binding interaction of Juglone with lysozyme: Spectroscopic studies aided by in silico calculations. J. Photochem. Photobiol. B Biol. 2019, 193, 89–99. [Google Scholar] [CrossRef]
- Millan, S.; Satish, L.; Bera, K.; Susrisweta, B.; Singh, D.V.; Sahoo, H. A spectroscopic and molecular simulation approach toward the binding affinity between lysozyme and phenazinium dyes: An effect on protein conformation. J. Phys. Chem. B 2017, 121, 1475–1484. [Google Scholar] [CrossRef] [PubMed]
- Das, S.; Santra, S.; Rohman, M.A.; Ray, M.; Jana, M.; Roy, A.S. An insight into the binding of 6-hydroxyflavone with hen egg white lysozyme: A combined approach of multi-spectroscopic and computational studies. J. Biomol. Struct. Dyn. 2018, 37, 4019–4034. [Google Scholar] [CrossRef] [PubMed]
- Das, S.; Pahari, S.; Sarmah, S.; Rohman, M.A.; Paul, D.; Jana, M.; Roy, A.S. Lysozyme–luteolin binding: Molecular insights into the complexation process and the inhibitory effects of luteolin towards protein modification. Phys. Chem. Chem. Phys. 2019, 21, 12649–12666. [Google Scholar] [CrossRef] [PubMed]
- He, W.; Li, Y.; Tang, J.; Luan, F.; Jin, J.; Hu, Z. Comparison of the characterization on binding of alpinetin and cardamonin to lysozyme by spectroscopic methods. Int. J. Biol. Macromol. 2006, 39, 165–173. [Google Scholar] [CrossRef]
- Alam, P.; Chaturvedi, S.K.; Siddiqi, M.K.; Rajpoot, R.K.; Ajmal, M.R.; Zaman, M.; Khan, R.H. Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases. Sci. Rep. 2016, 6, 26759. [Google Scholar] [CrossRef] [Green Version]
- Ceresa, C.; Bravin, A.; Cavaletti, G.; Pellei, M.; Santini, C. The combined therapeutical effect of metal-based drugs and radiation therapy: The present status of research. Curr. Med. Chem. 2014, 21, 2237–2265. [Google Scholar] [CrossRef]
- Thompson, K.H.; Orvig, C. Metal complexes in medicinal chemistry: New vistas and challenges in drug design. Dalt. Trans. 2006, 14, 761–764. [Google Scholar] [CrossRef]
- Gyurcsik, B.; Nagy, L. Carbohydrates as ligands: Coordination equilibria and structure of the metal complexes. Coord. Chem. Rev. 2000, 203, 81–149. [Google Scholar] [CrossRef]
- Mohamed, E.; Genady, A.R.; Gabel, D. The first synthesis of azanonaborane-containing sugars, possible boron carriers for neutron capture therapy. New J. Chem. 2006, 30, 597–602. [Google Scholar]
- Karges, J. Combining inorganic chemistry and biology: The underestimated potential of metal complexes in medicine. ChemBioChem 2020, 21, 3044–3046. [Google Scholar] [CrossRef]
- Franz, K.J.; Metzler-Nolte, N. Introduction: Metals in medicine. Chem. Rev. 2019, 119, 727–729. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Rijt, S.H.; Sadler, P.J. Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. Drug Discov. Today 2009, 14, 1089–1097. [Google Scholar] [CrossRef] [Green Version]
- Parveen, S.; Cowan, J.A.; Yu, Z.; Arjmand, F. Enantiomeric copper based anticancer agents promoting sequence-selective cleavage of G-quadruplex telomeric DNA and non-random cleavage of plasmid DNA. Metallomics 2020, 12, 988–999. [Google Scholar] [CrossRef]
- Arjmand, F.; Sharma, S.; Parveen, S.; Toupet, L.; Yu, Z.; Cowan, J.A. Copper (II) l/d-valine-(1,10-phen) complexes target human telomeric G-quadruplex motifs and promote site-specific DNA cleavage and cellular cytotoxicity. Dalton Trans. 2020, 49, 9888–9899. [Google Scholar] [CrossRef] [PubMed]
- Parveen, S.; Fatima, K.; Zehra, S.; Arjmand, F. RNA-targeted Cu (II)-based potential antitumor drug entity: Comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies. J. Biomol. Struct. Dyn. 2020, 39, 6070–6083. [Google Scholar] [CrossRef]
- Parveen, S.; Tabassum, S.; Arjmand, F. Synthesis of chiral: R/S-pseudopeptide-based Cu(II) & Zn(II) complexes for use in targeted delivery for antitumor therapy: Enantiomeric discrimination with CT-DNA and pBR322 DNA hydrolytic cleavage mechanism. RSC Adv. 2017, 7, 6587–6597. [Google Scholar]
- Ronconi, L.; Sadler, P.J. Using coordination chemistry to design new medicines. Coord. Chem. Rev. 2007, 251, 1633–1648. [Google Scholar] [CrossRef]
- Parveen, S.; Arjmand, F.; Tabassum, S. Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action. Eur. J. Med. Chem. 2019, 175, 269–286. [Google Scholar] [CrossRef]
- Ong, Y.C.; Gasser, G. Organometallic compounds in drug discovery: Past, present and future. Drug Discov. Today Technol. 2019. [Google Scholar] [CrossRef]
- Gasser, G.; Metzler-Nolte, N. The potential of organometallic complexes in medicinal chemistry. Curr. Opin. Chem. Biol. 2012, 16, 84–91. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Arjmand, F.; Parveen, S.; Tabassum, S.; Pettinari, C. Organo-tin antitumor compounds: Their present status in drug development and future perspectives. Inorg. Chim. Acta 2014, 423, 26–37. [Google Scholar] [CrossRef]
- Parveen, S.; Tabassum, S.; Arjmand, F. Human topoisomerase I mediated cytotoxicity profile of l-valine-quercetin diorganotin (IV) antitumor drug entities. J. Organomet. Chem. 2016, 823, 23–33. [Google Scholar] [CrossRef]
- Kumar, M.; Abbas, Z.; Tuli, H.S.; Rani, A. Organotin Complexes with Promising Therapeutic Potential. Curr. Pharmacol. Rep. 2020, 6, 167–181. [Google Scholar] [CrossRef]
- Devi, J.; Yadav, J. Recent advancements in organotin (IV) complexes as potential anticancer agents. Anti-Cancer Agents Med. Chem. 2018, 18, 335–353. [Google Scholar] [CrossRef]
- Khan, R.A.; Yadav, S.; Hussain, Z.; Arjmand, F.; Tabassum, S. Carbohydrate linked organotin (IV) complexes as human topoisomerase Iα inhibitor and their antiproliferative effects against the human carcinoma cell line. Dalton Trans. 2014, 43, 2534–2548. [Google Scholar] [CrossRef]
- Tabassum, S.; Mathur, S.; Arjmand, F.; Mishra, K.; Banerjee, K. Design, synthesis, characterization and DNA-binding studies of a triphenyltin (IV) complex of N-glycoside (GATPT), a sugar based apoptosis inducer: In vitro and in vivo assessment of induction of apoptosis by GATPT. Metallomics 2012, 4, 205–217. [Google Scholar] [CrossRef] [PubMed]
- Rudra, S.; Jana, A.; Sepay, N.; Patel, B.K.; Mahapatra, A. Characterization of the binding of strychnine with bovine β-lactoglobulin and human lysozyme using spectroscopic, kinetic and molecular docking analysis. New J. Chem. 2018, 42, 8615–8628. [Google Scholar] [CrossRef]
- Lakowicz, J.R. Protein fluorescence. In Principles of Fluorescence Spectroscopy; Springer: Berlin/Heidelberg, Germany, 1983; pp. 341–381. [Google Scholar]
- Shirley, B.A. Theory and practice. In Protein Stability and Folding; Springer: Berlin/Heidelberg, Germany, 1995. [Google Scholar]
- Esquembre, R.; Sanz, J.M.; Wall, J.G.; Del Monte, F.; Mateo, C.R.; Ferrer, M.L. Thermal unfolding and refolding of lysozyme in deep eutectic solvents and their aqueous dilutions. Phys. Chem. Chem. Phys. 2013, 15, 11248–11256. [Google Scholar] [CrossRef] [Green Version]
- Khan, J.M.; Malik, A.; Ahmed, A.; Rehman, M.T.; AlAjmi, M.F.; Khan, R.H.; Fatima, S.; Alamery, S.F.; Abdullah, E.M. Effect of cetyltrimethylammonium bromide (CTAB) on the conformation of a hen egg white lysozyme: A spectroscopic and molecular docking study, Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2019, 219, 313–318. [Google Scholar] [CrossRef] [PubMed]
- Imoto, T.; Forster, L.S.; Rupley, J.A.; Tanaka, F. Fluorescence of lysozyme: Emissions from tryptophan residues 62 and 108 and energy migration. Proc. Natl. Acad. Sci. USA 1972, 69, 1151–1155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Parveen, S.; Usman, M.; Tabassum, S.; Arjmand, F. Synthesis and characterization of Co(II) and Fe(II) peptide conjugates as hydrolytic cleaving agents and their preferential enantiomeric disposition for CT-DNA: Structural investigation of L-enantiomers by DFT and molecular docking studies. RSC Adv. 2015, 5, 72121–72131. [Google Scholar] [CrossRef]
- Zeng, L.; Ding, H.; Hu, X.; Zhang, G.; Gong, D. Galangin inhibits α-glucosidase activity and formation of non-enzymatic glycation products. Food Chem. 2019, 271, 70–79. [Google Scholar] [CrossRef] [PubMed]
- Ding, H.; Wu, X.; Pan, J.; Hu, X.; Gong, D.; Zhang, G. New insights into the inhibition mechanism of betulinic acid on α-glucosidase. J. Agric. Food Chem. 2018, 66, 7065–7075. [Google Scholar] [CrossRef] [PubMed]
- Ni, M.; Hu, X.; Gong, D.; Zhang, G. Inhibitory mechanism of vitexin on α-glucosidase and its synergy with acarbose. Food Hydrocoll. 2020, 105, 105824. [Google Scholar] [CrossRef]
- Kashanian, S.; Zeidali, S.H.; Omidfar, K.; Shahabadi, N. Multi-spectroscopic DNA interaction studies of sunset yellow food additive. Mol. Biol. Rep. 2012, 39, 10045–10051. [Google Scholar] [CrossRef] [PubMed]
- Kashanian, S.; Khodaei, M.M.; Kheirdoosh, F. In vitro DNA binding studies of aspartame, an artificial sweetener. J. Photochem. Photobiol. B Biol. 2013, 120, 104–110. [Google Scholar] [CrossRef]
- Fathi, F.; Sharifi, M.; Jafari, A.; Kakavandi, N.; Kashanian, S.; Dolatabadi, J.E.N.; Rashidi, M.-R. Kinetic and thermodynamic insights into interaction of albumin with piperacillin: Spectroscopic and molecular modeling approaches. J. Mol. Liq. 2019, 296, 111770. [Google Scholar] [CrossRef]
- Mohammadzadeh-Aghdash, H.; Dolatabadi, J.E.N.; Dehghan, P.; Panahi-Azar, V.; Barzegar, A. Multi-spectroscopic and molecular modeling studies of bovine serum albumin interaction with sodium acetate food additive. Food Chem. 2017, 228, 265–269. [Google Scholar] [CrossRef]
- Fathi, F.; Mohammadzadeh-Aghdash, H.; Sohrabi, Y.; Dehghan, P.; Dolatabadi, J.E.N. Kinetic and thermodynamic studies of bovine serum albumin interaction with ascorbyl palmitate and ascorbyl stearate food additives using surface plasmon resonance. Food Chem. 2018, 246, 228–232. [Google Scholar] [CrossRef]
- Dolatabadi, J.E.N.; Panahi-Azar, V.; Barzegar, A.; Jamali, A.A.; Kheirdoosh, F.; Kashanian, S.; Omidi, Y. Spectroscopic and molecular modeling studies of human serum albumin interaction with propyl gallate. RSC Adv. 2014, 4, 64559–64564. [Google Scholar] [CrossRef]
- Ding, F.; Zhao, G.; Huang, J.; Sun, Y.; Zhang, L. Fluorescence spectroscopic investigation of the interaction between chloramphenicol and lysozyme. Eur. J. Med. Chem. 2009, 44, 4083–4089. [Google Scholar] [CrossRef]
- Alam, P.; Rabbani, G.; Badr, G.; Badr, B.M.; Khan, R.H. The Surfactant-Induced Conformational and Activity Alterations in Rhizopus niveus Lipase. Cell Biochem. Biophys. 2015, 71, 1199–1206. [Google Scholar] [CrossRef]
- Swain, B.C.; Mukherjee, S.K.; Rout, J.; Sakshi; Mishra, P.P.; Mukherjee, M.; Tripathy, U. A spectroscopic and computational intervention of interaction of lysozyme with 6-mercaptopurine. Anal. Bioanal. Chem. 2020, 412, 2565–2577. [Google Scholar] [CrossRef] [PubMed]
- Paul, B.K.; Ghosh, N.; Mukherjee, S. Binding interaction of a prospective chemotherapeutic antibacterial drug with β-lactoglobulin: Results and challenges. Langmuir 2014, 30, 5921–5929. [Google Scholar] [CrossRef]
- Jash, C.; Basu, P.; Payghan, P.V.; Ghoshal, N.; Kumar, G.S. Chelerythrine–lysozyme interaction: Spectroscopic studies, thermodynamics and molecular modeling exploration. Phys. Chem. Chem. Phys. 2015, 17, 16630–16645. [Google Scholar] [CrossRef]
- Zhang, B.; Tao, H.; Niu, X.; Li, S.; Chen, H.-Q. Lysozyme distribution, structural identification, and in vitro release of starch-based microgel-lysozyme complexes. Food Chem. 2017, 227, 137–141. [Google Scholar] [CrossRef] [PubMed]
- Khan, H.Y.; Tabassum, S.; Arjmand, F. Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu (II) & Zn (II) DACH–mefenamato drug conjugates against human cancer cell lines. RSC Adv. 2020, 10, 166–178. [Google Scholar]
- Ishtikhar, M.; Usmani, S.S.; Gull, N.; Badr, G.; Mahmoud, M.H.; Khan, R.H. Inhibitory effect of copper nanoparticles on rosin modified surfactant induced aggregation of lysozyme. Int. J. Biol. Macromol. 2015, 78, 379–388. [Google Scholar] [CrossRef]
T (K) | K (105 M−1) | Ksv (105 M−1) | KD (µM) | Binding Site (n) | ∆H (kJ mol−1) | ∆S (J k−1 mol−1) | ∆G (kJ mol−1) |
---|---|---|---|---|---|---|---|
298 | 2.32 | 4.05 | 4.31 | 0.932 | −59.46 | 92.06 | −86.89 |
303 | 1.63 | 3.32 | 6.13 | 1.010 | −87.35 | ||
308 | 1.06 | 1.39 | 9.43 | 1.014 | −87.81 | ||
313 | 0.76 | 0.89 | 13.15 | 1.056 | −88.274 |
Amino Acid Residues | Interaction Involved |
---|---|
Glu35 | Hydrogen bonding |
Asn46 | |
Arg112 | Hydrophobic |
Gln57 | |
Ala107 | |
Ile58 | |
Asn44 | |
Asn46 | |
Asp48 | |
Asp52 | |
Trp62 | |
Trp63 | |
Trp108 | |
Ser50 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Parveen, S.; Ali, M.S.; Al-Lohedan, H.A.; Tabassum, S. Interaction of Carrier Protein with Potential Metallic Drug Candidate N-Glycoside ‘GATPT’: Validation by Multi-Spectroscopic and Molecular Docking Approaches. Molecules 2021, 26, 6641. https://doi.org/10.3390/molecules26216641
Parveen S, Ali MS, Al-Lohedan HA, Tabassum S. Interaction of Carrier Protein with Potential Metallic Drug Candidate N-Glycoside ‘GATPT’: Validation by Multi-Spectroscopic and Molecular Docking Approaches. Molecules. 2021; 26(21):6641. https://doi.org/10.3390/molecules26216641
Chicago/Turabian StyleParveen, Sabiha, Mohd. Sajid Ali, Hamad A. Al-Lohedan, and Sartaj Tabassum. 2021. "Interaction of Carrier Protein with Potential Metallic Drug Candidate N-Glycoside ‘GATPT’: Validation by Multi-Spectroscopic and Molecular Docking Approaches" Molecules 26, no. 21: 6641. https://doi.org/10.3390/molecules26216641